Key Summary: On October 26, 2023, Galloway (4.3%) urged the company to explore strategic alternatives, including a sale, due to poor stock performance, and proposed a board nominee with capital markets experience. Previously, Nokomis Capital, once a 15.4% holder, engaged actively from 2017–2019, securing board seats through agreements before trimming its stake to 9.9% by May 2020.